Archives Market Prospects for Hemodialysis and Peritoneal Dialysis

The dialysis treatment includes hemodialysis to purify the blood using an artificial kidney (dialyzer) and peritoneal dialysis to purify the blood through its own peritoneum. There are two types of dialysis: hemodialysis and peritoneal dialysis. Hemodialysis involves the purification of blood by removing waste and excess fluids using the dialyzer membrane. The purified blood is then reintroduced into the body. Peritoneal dialysis involves purifying the blood using the patient's own peritoneum as a dialysis membrane. Patients with chronic kidney disease are usually maintained on dialysis and normal renal function can only be achieved by kidney transplantation. Click to learn more about Market for hemodialysis and peritoneal dialysis

Market factors of hemodialysis and peritoneal dialysis

Innovative product launches at leading manufacturers, mergers and acquisitions, and manufacturers' initiatives to support and compete in the global market for hemodialysis and peritoneal dialysis are expected to spur growth in the global marketplace. hemodialysis and peritoneal dialysis. For example, leading manufacturers such as Fresenius Medical Care AG and Co. KGaA focus on product launches as well as mergers and acquisitions.

Fresenius Medical Care supported the recommendation of the National Institute of Health and Care Excellence (NICE) to facilitate the management of population health care for British patients with deficiency end stage renal disease using hemodiafiltration (HDF) rather than a high-flux hemodialysis (HD) in October 2018 This should stimulate the growth of the global market for hemodialysis and peritoneal dialysis during the forecast period.

In addition, Fresenius Medical Care and Humacyte, Inc. signed a strategic partnership in November 2018. Humacyte has developed HUMACYL, which is currently the focus of a vascular access study for # 39; hemodialysis. In addition, in April 2018, Fresenius Medical Care won the Red Dot Award: Product Design for the company's 6008 CAREset blood line system used in hemodialysis.

In addition, Fresenius Medical Care signed an agreement in 2017 for the acquisition of NxStage Medical, Inc. (NxStage), an American company specializing in medical technologies and services. B. Braun Medical, Inc. Signed an Agreement for the Acquisition of Name Medisystems' Ligning Activities of NxStage Medical, Inc. In 2017, NxStage Medical, Inc. announced that the Food and Drug Administration (FDA) United States authorized System One to perform a solo hemodialysis. These factors should support the growth of the global market for hemodialysis and peritoneal dialysis during the forecast period.

Strict regulatory policies for the approval and manufacture, reimbursement, risks and complications badociated with dialysis treatment should limit the growth of global markets for hemodialysis and peritoneal dialysis during the period forecast.

Request an example copy of this Activity Report @ https://www.coherentmarketinsights.com/insight/request-sample/2327

Key players in the market for hemodialysis and peritoneal dialysis

The main players in the global market for hemodialysis and peritoneal dialysis include Fresenius Medical Care AG & Co. KGaA, DaVita Healthcare Partners, Inc., Baxter International, Inc., B. Braun Melsungen AG, Nipro Corporation, Diaverum Deutschland GmbH and Nikkiso Co. Ltd., Asahi Kasei Corporation and NxStage Medical, Inc.

Regional Market Analysis of Hemodialysis and Peritoneal Dialysis

The hemodialysis and peritoneal dialysis market in North America is expected to dominate the global market over the forecast period. The presence of leading manufacturers as well as the increasing number of dialysis procedures should support the growth of the global market for hemodialysis and peritoneal dialysis. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), more than 661,000 people in the United States were suffering from kidney failure and 468,000 of them were on dialysis in 2017 These factors have contributed to the growth of the hemodialysis and peritoneal dialysis market in North America.